Private Advisor Group, LLC Adma Biologics, Inc. Transaction History

Private Advisor Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$1.43 - $2.2 $14,300 - $22,000	-10,000 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.28 - $1.83 $12,800 - $18,300	10,000 New	10,000 $18,000
Q3 2020 Nov 02, 2020	SELL	$2.04 - $3.74 $3,978 - $7,293	-1,950 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$2.42 - $3.29 $35,445 - $48,188	-14,647 Reduced 88.25%	1,950 $6,000
Q1 2020 May 12, 2020	BUY	$1.5 - $4.59 $117 - $358	78 Added 0.47%	16,597 $48,000

Q4 2019 Feb 10, 2020	BUY	$3.89 - $5.15 $73 - $97	19 Added 0.12%	16,519 $66,000
Q3 2019 Nov 13, 2019	SELL	$3.19 - $5.39 $3,333 - $5,632	-1,045 Reduced 5.96%	16,500 $74,000
Q2 2019 Aug 14, 2019	BUY	$3.52 - $5.24 $7,198 - $10,715	2,045 Added 13.19%	17,545 $67,000
Q4 2018 Feb 11, 2019	BUY	$2.17 - $6.12 $5,859 - $16,524	2,700 Added 21.09%	15,500 $35,000
Q3 2018 Nov 01, 2018	SELL	$4.39 - $6.85 $172,487 - $269,143	-39,291 Reduced 75.43%	12,800 $79,000
Q2 2018 Aug 09, 2018	BUY	$4.39 - $5.44 $228,679 - $283,375	52,091 New	52,091 $235,000

224

174M

85.5K

12.8K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $2.2B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.